@FierceBiotech: Labopharm slashes staff, pushes strategic review. News | Follow @FierceBiotech
@JohnCFierce: Looks like Peptimmune is heading off into the sunset. Article | Follow @JohnCFierce
> Seattle-based Omeros says that its experimental therapy for patients undergoing cataract surgery proved promising in a mid-stage study, paving the way to a pivotal Phase III trial. Story
> Shares of Pozen jumped five percent this morning after it announced that it had licensed some Latin American rights to its migraine drug MT400 to a unit of J&J for an undisclosed upfront fee and milestones. Report
> Quintiles says that it has shelved financing plans outlined earlier in the month. Story
> After seeing its share price shoot up Prana Biotechnology in Australia is raising a little more than $6 million through a private placement. Prana release
> RTU and Sucampo Manufacturing and Research AG inked a licensing agreement to develop, manufacture, and commercialize Unoprostone (Rescula) in regions excluding Japan, Taiwan, Republic of Korea, the People's Republic of China and North America. Report
Pharma News
> With Sanofi-Merck deal off, look for animal health M&A. Report
> Payers may balk at Makena pricing, KV says. Story
> Bill would require Medicare to pay for off-label meds. Article
> SC jury finds J&J letter violated consumer laws. Story
> Pfizer chiefs new and old get big bumps in pay. News
> Pfizer in talks with feds on Protonix rebate charges. Report
Drug Delivery News
> Tekmira sues RNAi drug-delivery partner Alnylam. Report
> Puzzle solved to deliver RNA drugs into brain. News
> MRI guides cancer drug directly to liver. Story
> Startup with "spidersilk" for drug delivery raises $7M. Item
> OncoSec, cancer drug delivery firm, taking form. Article
> More cancer-killing gold found in gold nanoparticles? Story
Medical Device News
> ACT study aims to demonstrate safety, efficacy of TEMPASURE catheter. News
> Ex-Exactech rep to pay $56K for role in kickback scheme. Story
> Terumo unit enters consent decree, gives up $35M in profits. Article
> St. Jude shares up on JP Morgan analyst note. Report
> ReGen says it's fed up with FDA's 'agenda,' refuses hearing. News
> Nordion to evaluate TheraSphere in PhIII. Story
> Core Essence raises $11.5M in Series B funding. Article
And Finally... Investigators at Tufts Medical Center say that occasional sex significantly raises the risk of a heart attack. Story